Abstract
A case of active prosthetic valve infective endocarditis (PVE) due toCandida glabrata was successfully treated by the systemic administration of fluconazole. A 66-year-old Japanese man with infective endocarditis of unknown etiology underwent aortic and mitral valve replacement to treat severe aortic and mitral regurgitation associated with multiple organ failure. Postsurgical cultures of arterial blood were repeatedly positive forC. glabrata, and therefore fluconazole was administered either intravenously or orally at a dose of 400 mg/day for 46 days. During that time the signs of inflammation including fever such as an elevated white blood cell count and the presence of C-reactive protein (CRP) all improved while the blood cultures became negative. Fluconazole is thus considered to be effective in treating PVE caused byC. glabrata. When administering this treatment, it is also important to monitor the patient's renal and liver function.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Turnier E, Kay JH, Bernstein S, Mendez AM, Zubiate P (1975) Surgical treatment ofCandida endocarditis. Chest 67:262–268
Mayumi H, Matsuzaki K, Kawachi Y, Kinoshita K, Tominaga R, Tokunaga K (1991) Novel method of valve replacement with interrupted suture using protractor rings for the partitioning of a prosthetic sewing ring. Artif Organs 15:503–506
Mayumi H, Tokunaga K (1992) Continuous intravenous infusion of chlorpromazine for both sedation and after-load reduction in postcardiotomy patients under intraaortic balloon pumping. Jpn Heart J 33:61–71
Isalska BJ, Stanbridge TN (1988) Fluconazole in the treatment of candidal prosthetic valve endocarditis. Br Med J 297:178–179
Boyce JMH (1975) A case of prosthetic valve endocarditis caused byCorynebacterium hofmanni andCandida albicans. Br Heart J 37:1195–1197
Galgiani JN, Stevens DA (1977) Fungal endocarditis: need for guidelines in evaluating therapy: experience with two patients previously reported. J Thorac Cardiovasc Surg 73:293–296
Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ (1985) Risk factors for the development of prosthetic valve endocarditis. Circulation 72:31–37
Rocchiccioli C, Chastre J, Lecompte Y, Grandjbakhch I, Gibert C (1986) Prosthetic valve endocarditis. J Thorac Cardiovasc Surg 92:776–783
Sett SS, Hudon MPJ, Jamieson WRE, Chow AW (1993) Prosthetic valve endocarditis. J Thorac Cardiovasc Surg 105:428–434
Seeling MS, Speth CP, Kozinn PJ, Toni EF, Taschdjian CL (1973)Candida endocarditis after cardiac surgery. J Thorac Cardiovasc Surg 65:583–601
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishida, T., Mayumi, H., Kawachi, Y. et al. The efficacy of fluconazole in treating prosthetic valve endocarditis caused byCandida glabrata: Report of a case. Surg Today 24, 651–654 (1994). https://doi.org/10.1007/BF01833735
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01833735